Ticovac Injection
Product Images NDC 0069-0411
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ticovac (NDC 0069-0411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (0.25 mL Syringe Label)
This is a description of a Tick-Borne Encephalitis Vaccine called TICOVACâ„¢ by Pfizer Ireland Pharmaceuticals. The vaccine comes in a one-dose-size of 0.25 mL and is for intramuscular use only. It is important to refrigerate the vaccine and not freeze it. The bottle must be shaken well before use. The LOT/EXP number is not available in the text. The product is only available by prescription.*
Principal Display Panel (0.25 mL Syringe Carton)
Principal Display Panel (0.25 mL Syringe Carton)
Principal Display Panel (0.5 mL Syringe Label)
Tick-Borne Encephalitis Vaccine, brand name TICOVAC, is a one-dose intramuscular vaccine that comes in a 0.5 mL vial. It is intended for use in the United States, as indicated by the US License No. 2060 printed on the label. The manufacturer is Pfizer Ireland Pharmaceuticals. The lot number and expiration date are indicated as PAA178116 and could vary depending upon the specific product. The product should be refrigerated and shaken well prior to use.*
Pprincipal Display Panel (0.5 mL Syringe Carton)
Principal Display Panel (0.5 mL Syringe Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.